Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Fall risk-increasing drugs and associated health outcomes among community-dwelling older patients: A cross-sectional study in Croatian cohort of the EuroAgeism H2020 project

E. Paar, E. De Lai, M. Držaić, I. Kummer, I. Bužančić, MO. Hadžiabdić, J. Brkic, D. Fialová

. 2024 ; 74 (4) : 635-653. [pub] 20250109

Jazyk angličtina Země Polsko

Typ dokumentu časopisecké články, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc25010302

Our study aimed to assess the prevalence of fall risk-increasing drugs (FRIDs) in a sample of community-residing older patients in Croatia and its association with negative health outcomes. An observational, cross-sectional study was conducted on older patients (65+) visiting community pharmacies in three regionally different study sites in Croatia. Data were collected using a questionnaire developed for that purpose and included components of comprehensive geriatric assessment. Prevalence of FRIDs was identified using the "Screening Tool of Older Persons Prescriptions in older adults with high fall risk" (STOPPFall). In the sample of 407 participants (median age 73 (IQR 69-70) years; 63.9 % females), 79.1 % used at least one FRID. The most common drug classes were diuretics, benzodiazepines, and opioids (in 51.1 %, 38.1 %, and 17.2 % participants, respectively). More FRIDs were prescribed to the oldest old patients (85+) and participants from poorer regions of Croatia (Slavonia) (p < 0.05). Exposition to FRIDs was identified as the significant risk factor associated with falls (OR = 1.24 (1.04-1.50); p = 0.020) and higher health-care utilization (OR = 1.29 (1.10-1.51); p = 0.001). Our study highlights the need for rationalization of FRID use. To reduce the unnecessary exposure to FRIDs in older adults, health-care professionals must consider high individualization of medication schemes regarding selection, dosing, and combinations of only necessary FRIDs.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010302
003      
CZ-PrNML
005      
20250429134450.0
007      
ta
008      
250415s2024 pl f 000 0|eng||
009      
AR
024    7_
$a 10.2478/acph-2024-0034 $2 doi
035    __
$a (PubMed)39560349
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Paar, Elizabeta $u University of Zagreb Faculty of Pharmacy and Biochemistry, Center for Applied Pharmacy, Zagreb, Croatia
245    10
$a Fall risk-increasing drugs and associated health outcomes among community-dwelling older patients: A cross-sectional study in Croatian cohort of the EuroAgeism H2020 project / $c E. Paar, E. De Lai, M. Držaić, I. Kummer, I. Bužančić, MO. Hadžiabdić, J. Brkic, D. Fialová
520    9_
$a Our study aimed to assess the prevalence of fall risk-increasing drugs (FRIDs) in a sample of community-residing older patients in Croatia and its association with negative health outcomes. An observational, cross-sectional study was conducted on older patients (65+) visiting community pharmacies in three regionally different study sites in Croatia. Data were collected using a questionnaire developed for that purpose and included components of comprehensive geriatric assessment. Prevalence of FRIDs was identified using the "Screening Tool of Older Persons Prescriptions in older adults with high fall risk" (STOPPFall). In the sample of 407 participants (median age 73 (IQR 69-70) years; 63.9 % females), 79.1 % used at least one FRID. The most common drug classes were diuretics, benzodiazepines, and opioids (in 51.1 %, 38.1 %, and 17.2 % participants, respectively). More FRIDs were prescribed to the oldest old patients (85+) and participants from poorer regions of Croatia (Slavonia) (p < 0.05). Exposition to FRIDs was identified as the significant risk factor associated with falls (OR = 1.24 (1.04-1.50); p = 0.020) and higher health-care utilization (OR = 1.29 (1.10-1.51); p = 0.001). Our study highlights the need for rationalization of FRID use. To reduce the unnecessary exposure to FRIDs in older adults, health-care professionals must consider high individualization of medication schemes regarding selection, dosing, and combinations of only necessary FRIDs.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a úrazy pádem $x statistika a číselné údaje $7 D000058
650    _2
$a kohortové studie $7 D015331
650    _2
$a průřezové studie $7 D003430
650    _2
$a geriatrické hodnocení $x metody $7 D015577
650    12
$a samostatný způsob života $7 D057187
650    _2
$a polypharmacy $7 D019338
650    _2
$a prevalence $7 D015995
650    _2
$a rizikové faktory $7 D012307
650    _2
$a průzkumy a dotazníky $7 D011795
650    12
$a diskriminace na základě věku $7 D063506
651    _2
$a Chorvatsko $x epidemiologie $7 D017523
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a De Lai, Eleonora $u University of Zagreb Faculty of Pharmacy and Biochemistry, Center for Applied Pharmacy, Zagreb, Croatia
700    1_
$a Držaić, Margita $u University of Zagreb Faculty of Pharmacy and Biochemistry, Center for Applied Pharmacy, Zagreb, Croatia $u City Pharmacy Zagreb, Zagreb Croatia $1 https://orcid.org/0000000215394482
700    1_
$a Kummer, Ingrid $u Charles University, Faculty of Pharmacy, Department of Social and Clinical Pharmacy, Hradec Králové Czech Republic $1 https://orcid.org/0000000302051576
700    1_
$a Bužančić, Iva $u University of Zagreb Faculty of Pharmacy and Biochemistry, Center for Applied Pharmacy, Zagreb, Croatia $u City Pharmacy Zagreb, Zagreb Croatia $1 https://orcid.org/0000000241408657
700    1_
$a Hadžiabdić, Maja Ortner $u University of Zagreb Faculty of Pharmacy and Biochemistry, Center for Applied Pharmacy, Zagreb, Croatia $1 https://orcid.org/0000000315789764
700    1_
$a Brkic, Jovana $u Charles University, Faculty of Pharmacy, Department of Social and Clinical Pharmacy, Hradec Králové Czech Republic $1 https://orcid.org/0000000289718400 $7 xx0258102
700    1_
$a Fialová, Daniela $u Charles University, Faculty of Pharmacy, Department of Social and Clinical Pharmacy, Hradec Králové Czech Republic $u Charles University, 1st Faculty of Medicine, Department of Geriatrics and Gerontology, Prague, Czech Republic $1 https://orcid.org/0000000156389690
773    0_
$w MED00000116 $t Acta pharmaceutica $x 1846-9558 $g Roč. 74, č. 4 (2024), s. 635-653
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39560349 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134446 $b ABA008
999    __
$a ok $b bmc $g 2311578 $s 1247383
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 74 $c 4 $d 635-653 $e 20250109 $i 1846-9558 $m Acta pharmaceutica $n Acta Pharm $x MED00000116
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...